The changes in the plasma level of SNORD13 in symptomatic HD patients were highly significant compared to those of both the pre-HD and the three control groups (HS, PP, and AD; Figure 1 B, Table 2 ).
← all excerpts
Circulating U13 Small Nucleolar RNA as a Potential Biomarker in Huntington's Disease: A Pilot Study.
1
—
—